Structure Therapeutics Inc.
GPCR
Revenue
0.00
0.000.00%
-Assets
947.03M
▲489.80M▲107.13%
3 Months ChangeLiabilities
26.00M
▼-1.41M▼-5.14%
3 Months ChangeFree Cash Flow
-34.24M
▼-20.66M▼-152.09%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-17
Form 8-K
ID: 0001104659-24-100668
2024-08-27
Form 8-K
ID: 0001104659-24-093434
2024-08-08
Form 10-Q
ID: 0001558370-24-011616
2024-08-08
Form 8-K
ID: 0001104659-24-087275
2024-06-27
Form 8-K
ID: 0001104659-24-075724
2024-06-03
Form 8-K
ID: 0001104659-24-067836
2024-06-03
Form 8-K
ID: 0001104659-24-067483
2024-05-09
Form 10-Q
ID: 0001558370-24-007642
2024-05-09
Form 8-K
ID: 0001104659-24-059329
2024-03-08
Form 8-K
ID: 0001104659-24-032121